Related Experiment Videos
Abdominal lymphoma--the place for surgery.
A D Baildam1, G T Williams, P F Schofield
1Department of Surgery, Christie Hospital, Manchester.
Journal of the Royal Society of Medicine
|November 1, 1989
Summary
Gastrointestinal lymphoma (GIL) is rare and often misdiagnosed, delaying treatment. Complete surgical resection before chemotherapy significantly improves survival rates for patients with this condition.
Area of Science:
- Gastroenterology
- Surgical Oncology
- Oncology
Background:
- Gastrointestinal lymphoma (GIL) is a rare malignancy.
- Symptoms often mimic benign abdominal conditions, leading to surgical presentation.
- Delayed diagnosis is common due to non-specific symptoms and inaccurate initial investigations.
Purpose of the Study:
- To evaluate the diagnostic challenges and treatment outcomes for gastrointestinal lymphoma.
- To assess the impact of surgical resection extent on patient survival.
- To emphasize the role of surgical management in GIL.
Main Methods:
- Retrospective analysis of 55 patients with GIL treated between 1975 and 1984.
- Review of diagnostic methods (endoscopy, radiology, CT scans) and surgical procedures.
- Correlation of surgical resection extent with 3-year survival rates.
Main Results:
- 42% of patients experienced diagnostic delays of >= 6 months; 31% had delays of >= 1 year.
- Endoscopy and radiology frequently suggested other conditions like peptic ulceration or Crohn's disease.
- Complete surgical resection was associated with significantly better survival (14/16 survivors) compared to diagnostic biopsy only (1/28 survivors; P < 0.0001).
Conclusions:
- Early and accurate diagnosis is crucial for effective gastrointestinal lymphoma management.
- Complete surgical resection prior to chemotherapy is strongly recommended and improves outcomes.
- Experienced surgeons play a central role in the multidisciplinary management of GIL.